Citigroup’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.39M | Buy |
+15,000
| New | +$4.93M | ﹤0.01% | 2071 |
|
|
2025
Q2 | – | Sell |
-5,800
| Closed | -$2.52M | – | 5715 |
|
|
2025
Q1 | $2.52M | Hold |
5,800
| – | – | ﹤0.01% | 2499 |
|
|
2024
Q4 | $2.14M | Hold |
5,800
| – | – | ﹤0.01% | 2764 |
|
|
2024
Q3 | $3.02M | Hold |
5,800
| – | – | ﹤0.01% | 2306 |
|
|
2024
Q2 | $3.14M | Hold |
5,800
| – | – | ﹤0.01% | 1979 |
|
|
2024
Q1 | $3.01M | Buy |
+5,800
| New | +$2.88M | ﹤0.01% | 2090 |
|
|
2023
Q1 | – | Sell |
-6,000
| Closed | -$3.08M | – | 5592 |
|
|
2022
Q4 | $3.08M | Hold |
6,000
| – | – | ﹤0.01% | 1751 |
|
|
2022
Q3 | $2.73M | Sell |
6,000
-30,000
| -83% | -$14.4M | ﹤0.01% | 1925 |
|
|
2022
Q2 | $17.4M | Buy |
36,000
+30,000
| +500% | +$14.8M | 0.01% | 868 |
|
|
2022
Q1 | $2.95M | Sell |
6,000
-4,000
| -40% | -$1.83M | ﹤0.01% | 2034 |
|
|
2021
Q4 | $4.63M | Sell |
10,000
-50,000
| -83% | -$21M | ﹤0.01% | 1892 |
|
|
2021
Q3 | $22.4M | Buy |
+60,000
| New | +$22.8M | 0.01% | 930 |
|
|
2021
Q2 | – | Sell |
-35,000
| Closed | -$12.6M | – | 6187 |
|
|
2021
Q1 | $12.6M | Sell |
35,000
-85,500
| -71% | -$27.5M | 0.01% | 1232 |
|
|
2020
Q4 | $38.7M | Sell |
120,500
-128,100
| -52% | -$39.3M | 0.02% | 676 |
|
|
2020
Q3 | $66.8M | Sell |
248,600
-95,900
| -28% | -$25.8M | 0.04% | 348 |
|
|
2020
Q2 | $90.6M | Buy |
344,500
+157,000
| +84% | +$41.9M | 0.07% | 241 |
|
|
2020
Q1 | $42.6M | Sell |
187,500
-67,600
| -26% | -$18.4M | 0.04% | 418 |
|
|
2019
Q4 | $77M | Buy |
255,100
+123,700
| +94% | +$34M | 0.06% | 320 |
|
|
2019
Q3 | $31.6M | Buy |
131,400
+27,500
| +26% | +$7.53M | 0.03% | 663 |
|
|
2019
Q2 | $29.3M | Buy |
103,900
+46,700
| +82% | +$12.8M | 0.02% | 704 |
|
|
2019
Q1 | $16.4M | Buy |
57,200
+5,200
| +10% | +$1.5M | 0.02% | 954 |
|
|
2018
Q4 | $13.7M | Buy |
52,000
+28,900
| +125% | +$7.95M | 0.01% | 1047 |
|
|
2018
Q3 | $6.33M | Sell |
23,100
-26,800
| -54% | -$6.96M | 0.01% | 1636 |
|
|
2018
Q2 | $11.9M | Sell |
49,900
-40,500
| -45% | -$9.38M | 0.01% | 1160 |
|
|
2018
Q1 | $19.9M | Sell |
90,400
-10,000
| -10% | -$2.35M | 0.02% | 784 |
|
|
2017
Q4 | $22.6M | Buy |
100,400
+20,700
| +26% | +$4.41M | 0.02% | 774 |
|
|
2017
Q3 | $15.1M | Buy |
79,700
+27,200
| +52% | +$5.18M | 0.01% | 956 |
|
|
2017
Q2 | $9.88M | Buy |
52,500
+20,000
| +62% | +$3.59M | 0.01% | 1149 |
|
|
2017
Q1 | $5.37M | Sell |
32,500
-6,800
| -17% | -$1.08M | ﹤0.01% | 1611 |
|
|
2016
Q4 | $5.65M | Sell |
39,300
-2,500
| -6% | -$335K | 0.01% | 1705 |
|
|
2016
Q3 | $5.24M | Buy |
41,800
+12,400
| +42% | +$1.6M | ﹤0.01% | 1629 |
|
|
2016
Q2 | $3.86M | Sell |
29,400
-800
| -3% | -$109K | ﹤0.01% | 1808 |
|
|
2016
Q1 | $4.2M | Sell |
30,200
-27,500
| -48% | -$3.67M | ﹤0.01% | 1703 |
|
|
2015
Q4 | $8.05M | Sell |
57,700
-37,000
| -39% | -$5.1M | 0.01% | 1319 |
|
|
2015
Q3 | $13.3M | Buy |
94,700
+16,400
| +21% | +$2.46M | 0.01% | 947 |
|
|
2015
Q2 | $12.9M | Sell |
78,300
-6,000
| -7% | -$959K | 0.01% | 1039 |
|
|
2015
Q1 | $13M | Buy |
84,300
+900
| +1% | +$128K | 0.01% | 1012 |
|
|
2014
Q4 | $10.5M | Sell |
83,400
-27,100
| -25% | -$3.35M | 0.01% | 1230 |
|
|
2014
Q3 | $13.2M | Buy |
110,500
+7,500
| +7% | +$860K | 0.01% | 1080 |
|
|
2014
Q2 | $11.1M | Sell |
103,000
-19,200
| -16% | -$1.98M | 0.01% | 1190 |
|
|
2014
Q1 | $12.2M | Sell |
122,200
-72,600
| -37% | -$6.57M | 0.01% | 1024 |
|
|
2013
Q4 | $18M | Buy |
194,800
+23,500
| +14% | +$2.09M | 0.02% | 831 |
|
|
2013
Q3 | $14.3M | Buy |
171,300
+11,600
| +7% | +$994K | 0.01% | 913 |
|
|
2013
Q2 | $13.1M | Buy |
+159,700
| New | +$12M | 0.01% | 906 |
|
Other funds holding ELV
VCM
VPM
Citigroup's ELV Position: Q1 2026 in Review
Citigroup increased its Elevance Health (ELV) stake by 10% in Q1 2026, buying an estimated $7.27M and bringing the position to 238,850 shares worth $69.9M. The position accounts for 0.03% of the portfolio, ranked #523.
Citigroup first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $174M in Q1 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Citigroup held 238,850 shares of Elevance Health worth $69.9M as of Q1 2026.
- Citigroup bought 22,122 Elevance Health shares in Q1 2026, an estimated $7.27M.
- Elevance Health made up 0.03% of Citigroup's portfolio in Q1 2026, its #523 holding.
- Citigroup first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- Citigroup's Elevance Health position peaked at $174M in Q1 2025.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.